Physician

Pranshu Bansal, MD

According to 2025 Medicare claims, Pranshu Bansal, MD (NPI: 1447548722) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is IRONWOOD PHYSICIANS, PC (NPI: 1740269299; TIN: 731636831) and primary practice location at 85206-6059. Bansal is affiliated with the Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under the REACH model.

Bansal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 635 traditional Medicare patients, billed 294,340 HCPCS/CPT codes, and received $4,541,909 in Medicare payments. The top billing code was A9552 (Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries). Part D data shows 1,702 prescription claims across 291 beneficiaries totaling $4,122,286 in drug costs, led by Brukinsa (Zanubrutinib). 2022 DME data shows 28 claims. Open Payments data shows 203 records totaling $21,253. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $289,313 to $4,541,909. Similarly, Part D prescription costs have moved sharply higher in recent years, from $225,485 to $4,122,286. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,066 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	203	27,885	$289,313
2018	525	111,040	$1,428,174
2019	578	120,454	$1,808,106
2020	596	124,874	$2,018,563
2021	615	91,309	$1,270,398
2022	742	260,640	$2,899,626
2023	731	300,248	$4,048,308
2024	635	294,340	$4,541,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	37	142	$225,485
2016	37	205	$220,419
2017	55	187	$156,450
2018	120	466	$923,632
2019	179	958	$2,100,428
2020	201	1,291	$3,329,664
2021	256	970	$1,991,902
2022	211	1,167	$1,885,428
2023	269	1,902	$3,769,582
2024	291	1,702	$4,122,286

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	55	$2,650
2019	N/R	99	$4,933
2020	N/R	28	$910
2021	N/R	N/R	N/R
2022	N/R	28	$906
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	110	133	$281
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	193	486	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	296	540	$64
71260	Ct scan of chest with contrast	98	136	$47
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	119	16,550	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	77	2,310	$902,976
Jakafi	Ruxolitinib Phosphate	36	1,080	$659,214
Tagrisso	Osimertinib Mesylate	38	1,140	$651,656
Revlimid	Lenalidomide	26	728	$429,172
Lenalidomide	Lenalidomide	28	777	$307,385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	203	$21,253	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pranshu Bansal, MD?

Tedicare shows public-source Medicare data for Pranshu Bansal, MD (NPI 1447548722), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pranshu Bansal, MD have ACO affiliation data?

Pranshu Bansal, MD is shown with ACO affiliation data for Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Pranshu Bansal, MD?

Pranshu Bansal, MD is linked to IRONWOOD PHYSICIANS, PC (billing NPI 1740269299) in the available physician profile data.

Does Pranshu Bansal, MD have Open Payments data?

Pranshu Bansal, MD has 203 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.